Results 141 to 150 of about 707,254 (245)

Evaluation of early C‐reactive protein kinetics as an early response marker in biliary tract cancer treated with combined chemoimmunotherapy: A multicenter observational study

open access: yesCancer, Volume 132, Issue 20, 15 October 2026.
Abstract Background Reliable prognostic biomarkers for treatment response in patients with biliary tract cancer (BTC) who receive chemoimmunotherapy are still lacking. The objective of this study was to evaluate the potential of early C‐reactive protein (CRP) kinetics as a tool for predicting survival in these patients.
Gabriel Allo   +19 more
wiley   +1 more source

Gallbladder carcinoma surgical therapy. An overview

open access: yes, 2006
Carcinoma of the gallbladder is the most frequent tumor of the extrahepatic biliary tract, and the fourth commonest upper gastrointestinal malignancy. Despite advances in preoperative diagnostic and surgical techniques, carcinoma of the gallbladder is ...
MERIGGI, FRANCESCO
core  

Sister mary joseph′s nodule as the first presentation of gallbladder carcinoma: A case report and literature review

open access: yesSahel Medical Journal, 2010
Metastatic umbilical deposits from abdominal and pelvic malignancy is termed Sister Mary Joseph′s nodule. Metastasis of gallbladder adenocarcinoma to the umbilicus is extremely rare, even rarer is for this metastasis to be the initial presentation of ...
I Masoodi   +6 more
doaj  

Unveiling the molecular profile of adenosquamous gallbladder carcinoma: characterization of a Caucasian cohort. [PDF]

open access: yesHistopathology
Gasparello J   +20 more
europepmc   +1 more source

Acquired cystic disease-associated renal cell carcinoma mimicking gallbladder carcinoma. [PDF]

open access: yesUrol Case Rep
Kawaguchi Y   +4 more
europepmc   +1 more source

Case Report: Application of the 6D BTS digital assessment system in the comprehensive management of refractory cancer pain in a patient with gallbladder carcinoma. [PDF]

open access: yesFront Pain Res (Lausanne)
Ren J   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy